This can be attributed, particularly in breast cancer, to the presence of two subpopulations of CAFs within the lymph nodes: CAF-S1, which overexpresses FAP, and CAF-S4, which does not express FAP [178]. This evidence concerns the gene FAP and breast carcinoma.